Aurealis Therapeutics, a synthetic biology company developing ground-breaking four-in-one cell and gene therapies, announced today that...

Behind the success of BioNTech Pfizer and Moderna mRNA-based Covid vaccines, lays the story of 4 immigrants, Katalin Kariko, Ugur Sahin,...

With COVID-19 vaccine authorization, BioNTech SE and Pfizer open the door for massive acceleration of mRNA innovation, in...

Following Pfizer-BioNTech 90% efficacy announcement, Moderna data show 94% efficacy against Covid-19, while allowing easier storage: long...

mRNA treatments are about to revolutionize treatments of infectious and cancer diseases. After Covid-19 vaccines, next step will be...

After granting €252M to CureVac, the German government has awarded €375M to BioNTech. BioNtech announcement: https://lnkd.in/dKinEe4...

“We are thrilled to welcome Laurent to our Board of Directors,” said Juha Yrjänheikki, CEO of Aurealis Therapeutics. “His vast commercial...

More than 50 Covid-19 candidate vaccines are in development across the biotech and pharma industry, and multiple approaches are being...

Can we actually use mechanism used by cancer cells to avoid rejection and favor organ transplants ? #immunotherapy #organtransplant...

Organoids such as "mini-brains" or "mini-hearts" currently used in labs are very limited. How far are we from growing actual organs ?...

Patient with congenital blindness tested with CRISPR treatment for the first time. #genomics #patientoutcomes CRISPR technology, often...

Among 2019 top 10 Biotech IPOs Genmab's $505 million came #1, while BridgeBio Pharma, Gossamer Bio, Alector and BioNTech also joined the...